FDA label
What is Dayvigo used for?
Dayvigo contains lemborexant. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Dayvigo?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Dayvigo, tablet, film coated
Indications and Usage, quoted from the label by Eisai Inc. (NDA212028). Cross-references to other label sections are left out.
DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Source: DailyMed label, set id 7074cb65-77b3-45d2-8e8d-da8dc0f70bfd, version 39, effective February 24, 2025. NDC 62856-405, one of 2 listings for this product.
Questions
What is Dayvigo used for?
The FDA label says: “DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.”
What drug class is Dayvigo?
FDA lists lemborexant in the Orexin Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.